Documente Academic
Documente Profesional
Documente Cultură
- CAZ CLINIC -
*
Cnossen JS si colab. - Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine
growth restriction: a systematic review and bivariable meta-analysis. CMAJ, 2008;178:701–711.
DIAGNOSTIC SI TRATAMENT DE ETAPA
PROBE BIOLOGICE LA
S 30 – internare de urgenta
INTERNARE:
pentru:
-Hb= 13,7 g/dL; Ht=35%
-NT= 132 000/mmc
- dispnee cu ortopnee de
-Glicemie=101 mg/dL
12h
-Uree=30 mg/dL
- edeme periferice masive
-Creatinina=0,7 mg/dL
de 3 zile
-Ac. uric=2,9 mg/dL
- epigastralgii
-AST=57U/L; ALT=73U/L
- TA=150/115 mmHg
-INR=0,8; Fibrinogen=
604 mg/dL
ISTORICUL CAZULUI
S 30 – la 10h de la
PROBE BIOLOGICE
internare
-Asemanatoare cu cele
- dispnee cu ortopnee
de la internare
- edeme periferice masive
+ Glicemie = 235 mg/dL
- epigastralgii
- cefalee fronto-occipitala
EXAMEN ECO-DOPPLER
- TA=180/110 mmHg
- Fara suferinta fetala
DIAGNOSTIC SI TRATAMENT FINAL
Hiett AK, Brown HL, Britton KA. Outcome of infants delivered between 24 and 28 weeks’ gestation in women
with severe pre-eclampsia. J Matern Fetal Med
2001;10:301–304.
DIAGNOSTIC SI TRATAMENT FINAL
PROGNOSTICUL
HTA PACIENTELOR CU PRE-ECLAMPSIE
persistenta tratata de atunci cu EXFORGE ® (amlodipina
-Risc relativ
10 mg/valsartan 160 mgde -a1an,
dezvolta HTA
ulterior ulterior
APROVEL ® – 4x
(irbesartan)
-Risc relativ de boala cardiaca ischemica – 2x
150 mg/zi
Macroalbuminurie persistenta 1 an, urmata
Riscul cel mai mare
de microalbuminurie il au
pe care femeile
o are cu pre-eclampsie
si in prezent (dupa 3 1/2 ani)
precoce (<S32 de sarcina) sau intarziere in cresterea
fetala.
Duley L si colab. - Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database
Syst Rev 2007;2: CD004659; Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during
pregnancy for preventing hypertensive disorders and related problems. Cochrane Database
Syst Rev 2006;3:CD001059.
IN LOC DE CONCLUZII…